Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

mRNA microarray analysis in lymphoma and leukemia.

Timothy C Greiner1

  • 1Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, Nebraska, USA.

Cancer Treatment and Research
|June 26, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Challenges in Diagnosing High-grade B-cell Lymphoma, NOS: Poor Interobserver Agreement on Its Morphologic Definition-An LLMPP Study.

The American journal of surgical pathology·2026
Same author

Gene expression profiling reveals 2 overarching types of ALCL with distinct targetable biology: an LLMPP study.

Blood·2025
Same author

Functional genomics and tumor microenvironment analysis reveal prognostic biological subtypes in Mantle cell lymphoma.

Nature communications·2025
Same author

High-grade B-cell lymphoma, not otherwise specified: an LLMPP study.

Blood advances·2025
Same author

Integrative Genomic and Transcriptomic Analysis Reveals Targetable Vulnerabilities in Angioimmunoblastic T-Cell Lymphoma.

American journal of hematology·2025
Same author

DNA Methylation Epitypes of Burkitt Lymphoma with Distinct Molecular and Clinical Features.

Blood cancer discovery·2025
Same journal

Clinical Trials and Translational Advances in Metabolic Targeting.

Cancer treatment and research·2026
Same journal

Tools and Technologies for Studying Cancer Metabolism.

Cancer treatment and research·2026
Same journal

Cancer and Immune Cells: A Metabolic Battle in the Tumor Microenvironment.

Cancer treatment and research·2026
Same journal

Biomarkers of Cancer Metabolism and Therapeutic Response.

Cancer treatment and research·2026
Same journal

Targeting Metabolism in Cancer Therapy: Inhibitors and Approaches.

Cancer treatment and research·2026
Same journal

Metabolic Reprogramming in Cancer Stem Cells.

Cancer treatment and research·2026
See all related articles

Gene expression microarrays help classify lymphoma and leukemia subgroups, predict patient prognosis, and identify new therapeutic targets. These profiles will aid in developing advanced diagnostic and treatment strategies for blood cancers.

Area of Science:

  • Hematology
  • Molecular Biology
  • Oncology

Background:

  • Gene expression microarrays offer a powerful tool for understanding complex diseases.
  • Lymphoma and leukemia are cancers of the blood and lymphatic system with diverse subtypes.
  • Accurate characterization and prognosis are crucial for effective patient management.

Purpose of the Study:

  • To review the utility of gene expression microarrays in characterizing lymphoma and leukemia.
  • To explore the potential of gene expression profiles in predicting prognosis and guiding therapy.
  • To identify novel diagnostic markers and therapeutic targets.

Main Methods:

  • Review of studies utilizing gene expression microarrays in hematologic malignancies.
  • Analysis of gene expression data to identify correlations with cytogenetic abnormalities and clinical outcomes.

Related Experiment Videos

  • Evaluation of the predictive value of expression profiles for patient prognosis and treatment response.

    • Main Results:

    • Gene expression microarrays can effectively differentiate subgroups of lymphoma and leukemia.
    • Expression profiles correlate with known cytogenetic abnormalities and predict patient prognosis.
    • New proteins have been identified for diagnostic and follow-up purposes, alongside novel therapeutic targets.

    Conclusions:

    • Gene expression profiling is a valuable tool for the diagnosis, prognosis, and treatment of lymphoma and leukemia.
    • Future prognostic models will integrate gene expression data with traditional clinical and pathological assessments.
    • Gene expression profiles hold promise for predicting response to specific chemotherapeutic regimens, facilitating personalized medicine approaches.